Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 studyErica L. Mayer, Michael Gnant, Kathy D. Miller et al.|The Lancet Oncology|2021Cited by 255
Influence of histopathological changes after neoadjuvant chemotherapy on the survival of breast cancer patientsSabine Danzinger, Michael Seifert, Verena Heiss Spornberger et al.|Cancer Treatment and Research Communications|2025Cited by 2
Neoadjuvante endokrine Therapie und histopathologische Veränderungen beim Mammakarzinom – eine retrospektive AnalyseO Burger, Sabine Danzinger, Hannes Vietzen et al.|Geburtshilfe und Frauenheilkunde|2026Cited by 0